#biotechnews

Live, measured metrics for the hashtag #biotechnews from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #biotechnews

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$10.85/ year · 11-character #name
Claim #biotechnews — $10.85/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
7
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 7
0
Avg reactions / post
Mastodon · last 7
—
Reddit posts / month
Reddit search
—
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · mas.to (Mastodon public tags API) · fetched 2026-10-21 12:35 UTC
0
10-15
0
10-16
0
10-17
0
10-18
0
10-19
0
10-20
0
10-21

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · mas.to (Mastodon public search API) · fetched 2026-10-21 12:35 UTC

Live pulse

measured · mas.to (Mastodon tag timeline) · fetched 2026-10-21 12:35 UTC

Everything below is measured over the latest 7 public posts (spanning ~5642 hours).

Top of the latest posts

  • RADX Chief Medical Officer files initial ownership, signaling fresh investor confidence and leadership commitment. #RADX #StockMarket #InsiderBuying #BiotechNews https://meyka.com/blog/radx-chief-medical-officer-files-initial-ownership-may-

    sabamirza@[email protected]♥ 0↻ 02026-05-08 12:08 UTCView post →
  • China is no longer just a biotech market. It is increasingly a source of licensable innovation for global pharma. Sanofi’s up-to-$1.53B rovadicitinib deal is the latest signal — and part of a much bigger shift in where drug innovation begin

    Industry Examiner@[email protected]♥ 0↻ 02026-03-10 16:47 UTCView post →
  • FDA lifted the clinical hold on Intellia’s MAGNITUDE Phase 3 (ATTR-CM). The headline says “resume.” The real story: a safety reset—tighter selection + heavier liver monitoring + explicit mitigation steps. Our take: “conditional confidence”

    Industry Examiner@[email protected]♥ 0↻ 02026-03-03 15:05 UTCView post →

#biotechnews across platforms

every network with a public tag surface

Follow #biotechnews straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/biotechnews